Artios

Artios is on a mission to kill cancer by exploiting DNA damage response and repair pathways that are leveraged by cancer cells to promote their survival. Its specialized DcoDeR platform integrates Artios’ leadership capabilities, expertise and experience in DNA damage biology and drug discovery to systematically discover and develop medicines targeting the totality of the DDR.

Learn more at artios.com